Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder

Attention deficit hyperactivity disorder (ADHD) is a common, heritable neuropsychiatric disorder of unknown etiology. We performed a whole-genome copy number variation (CNV) study on 1,013 cases with ADHD and 4,105 healthy children of European ancestry using 550,000 SNPs. We evaluated statistically significant findings in multiple independent cohorts, with a total of 2,493 cases with ADHD and 9,222 controls of European ancestry, using matched platforms. CNVs affecting metabotropic glutamate receptor genes were enriched across all cohorts (P = 2.1 × 10−9). We saw GRM5 (encoding glutamate receptor, metabotropic 5) deletions in ten cases and one control (P = 1.36 × 10−6). We saw GRM7 deletions in six cases, and we saw GRM8 deletions in eight cases and no controls. GRM1 was duplicated in eight cases. We experimentally validated the observed variants using quantitative RT-PCR. A gene network analysis showed that genes interacting with the genes in the GRM family are enriched for CNVs in ∼10% of the cases (P = 4.38 × 10−10) after correction for occurrence in the controls. We identified rare recurrent CNVs affecting glutamatergic neurotransmission genes that were overrepresented in multiple ADHD cohorts.

Susanne Walitza | Aribert Rothenberger | Takeshi Sakurai | Herbert Roeyers | Tobias Banaschewski | Andreas Warnke | Gholson J Lyon | Philip Shaw | Dexter Hadley | Philip Asherson | Joseph T. Glessner | Hakon Hakonarson | Edmund Sonuga-Barke | Joseph Biederman | Marcin Imielinski | Jan Buitelaar | Cuiping Hou | Richard J L Anney | Barbara Franke | Susan L Smalley | Sandra K Loo | Stephen V Faraone | Marcel Romanos | Klaus-Peter Lesch | Haukur Pálmason | Nigel M Williams | Peter S White | Andreas Reif | Stanley F Nelson | Frank Mentch | B. Franke | J. Rapoport | R. Anney | C. Freitag | J. Glessner | H. Hakonarson | Cecilia Kim | S. Nelson | Kai Wang | J. Buxbaum | D. Hadley | S. Grant | K. Lesch | R. Ebstein | F. Middleton | J. Buitelaar | S. Faraone | M. Imieliński | N. Williams | J. Bradfield | E. Frackelton | R. Chiavacci | M. Devoto | J. Biederman | J. Sergeant | E. Mick | T. Banaschewski | S. Smalley | P. Shaw | H. Roeyers | R. Oades | A. Rothenberger | T. Sakurai | R. Robison | G. Lyon | S. Walitza | J. Gaynor | A. Warnke | E. Sonuga-Barke | P. Asherson | A. Reif | H. Steinhausen | P. White | S. Loo | T. Renner | F. Mentch | P. Sleiman | Haitao Zhang | C. Hou | N. Takahashi | M. Romanos | Jobst Meyer | J. Elia | L. Kent | A. Todorov | C. Rabin | H. Pálmason | Richard P Ebstein | Marcella Devoto | Joseph Sergeant | Hans-Christoph Steinhausen | F. Mulas | Jasmin Romanos | Josephine Elia | Joseph T Glessner | Joseph D Buxbaum | Nagahide Takahashi | Haitao Zhang | Kelly A. Thomas | Maria Garris | Kai Wang | Judith L Rapoport | Fernando Mulas | Jonathan P Bradfield | Cecilia E Kim | Kelly A Thomas | Edward C Frackelton | Rosetta M Chiavacci | Struan F A Grant | Reid Robison | Tobias J Renner | Jobst Meyer | Lindsey Kent | Robert D Oades | J. Flory | Frank A Middleton | Alexandre A Todorov | J William Gaynor | Corina J Shtir | Patrick M A Sleiman | J. Romanos | Christine M Freitag | Cara Rabin | James H Flory | Eric O Mick | Christiane Seitz | C. Seitz | M. Garris | Reid J. Robison | Kelly Thomas

[1]  E. Cook Genetics of attention‐deficit hyperactivity disorder , 1999 .

[2]  Paul W. Franks,et al.  Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden , 2009, Human molecular genetics.

[3]  C. Freitag,et al.  Evaluation der deutschen Version des Autismus-Spektrum-Quotienten (AQ) - die Kurzversion AQ-k , 2007 .

[4]  K. Mirnics,et al.  Genes and subtypes of schizophrenia. , 2001, Trends in molecular medicine.

[5]  T. B. Üstün,et al.  Patterns and Predictors of Attention-Deficit/Hyperactivity Disorder Persistence into Adulthood: Results from the National Comorbidity Survey Replication , 2005, Biological Psychiatry.

[6]  N. Bresolin,et al.  DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patients , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  M. Daly,et al.  Case-control genome-wide association study of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[9]  Aribert Rothenberger,et al.  Genome‐wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[10]  P. Riederer,et al.  Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression , 1999, Journal of Neural Transmission.

[11]  C. Freitag,et al.  A Highly Polymorphic Poly‐Glutamine Stretch in the Potassium Channel KCNN3 in Migraine , 2005, Headache.

[12]  K. Lesch,et al.  Cloning and functional characterization of the human norepinephrine transporter gene promoter , 1998, Journal of Neural Transmission.

[13]  Sharon J. Diskin,et al.  Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms , 2008, Nucleic acids research.

[14]  H. Taniura,et al.  A Metabotropic Glutamate Receptor Family Gene in Dictyostelium discoideum* , 2006, Journal of Biological Chemistry.

[15]  C. Freitag,et al.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.

[16]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[17]  Fassnacht,et al.  Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.

[18]  Benjamin M. Neale,et al.  Genome-wide association studies in ADHD , 2009, Human Genetics.

[19]  Susanne Walitza,et al.  Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  Y. Kohn Focus on rare genetic variants in bipolar disorder: how outliers help understand complex disorders. , 2005, The international journal of neuropsychopharmacology.

[21]  Jobst Meyer,et al.  Translocation breakpoints in three patients with campomelic dysplasia and autosomal sex reversal map more than 130 kb from SOX9 , 1996, Human Genetics.

[22]  N. Volkow,et al.  The neuroscience of addiction , 2005, Nature Neuroscience.

[23]  R Tannock,et al.  Association of the glutamate receptor subunit gene GRIN2B with attention‐deficit/hyperactivity disorder , 2007, Genes, brain, and behavior.

[24]  D. Stephan,et al.  No causative DLL4 mutations in periodic catatonia patients from 15q15 linked families , 2005, Schizophrenia Research.

[25]  R. Gainetdinov,et al.  Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Melissa L Wong The C/At is out of the bag: a gene for mental illness , 2001, The Pharmacogenomics Journal.

[27]  W Zieglgänsberger,et al.  Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. , 1999, Neuroreport.

[28]  Terje Sagvolden,et al.  A comparison of molecular alterations in environmental and genetic rat models of ADHD: A pilot study , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[29]  H. Hakonarson,et al.  Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A , 2009, Psychiatric genetics.

[30]  C. Yau,et al.  QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.

[31]  Hakon Hakonarson,et al.  Structural variations in attention-deficit hyperactivity disorder , 2011, The Lancet.

[32]  T. Wienker,et al.  hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophrenia , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[33]  Espen Borgå Johansen,et al.  The spontaneously hypertensive rat model of ADHD – The importance of selecting the appropriate reference strain , 2009, Neuropharmacology.

[34]  Daniel Mathalon,et al.  A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. , 2009, Schizophrenia bulletin.

[35]  J. Fogel,et al.  Metabolite Changes Resulting From Treatment in Children With ADHD: A 1H-MRS Study , 2003, Clinical neuropharmacology.

[36]  K. Lesch,et al.  Mutational analysis of the neuronal cadherin gene CELSR1 and exclusion as a candidate for catatonic schizophrenia in a large family , 2001, Psychiatric genetics.

[37]  P. Kelly,et al.  Antidepressant and anxiolytic‐like effects in mice lacking the group III metabotropic glutamate receptor mGluR7 , 2003, The European journal of neuroscience.

[38]  R. Oades,et al.  Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder , 1998, Psychiatry Research.

[39]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[40]  V. Russell Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder—the spontaneously hypertensive rat , 2003, Neuroscience & Biobehavioral Reviews.

[41]  K. Lesch,et al.  [The cadherin hypothesis of schizophrenia]. , 2003, Fortschritte der Neurologie-Psychiatrie.

[42]  J. Pin,et al.  Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.

[43]  T. Wienker,et al.  Exclusion of the neuronal nicotinic acetylcholine receptor α7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13–22 locus , 2002, Molecular Psychiatry.

[44]  W. Schulz,et al.  Gene order and genetic distance of 13 loci spanning murine chromosome 15. , 1992, Genomics.

[45]  S. Wüst,et al.  Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions , 2011, Human Genetics.

[46]  K. Lesch,et al.  Structural variation of the monoamine oxidase A gene promoter repeat polymorphism in nonhuman primates , 2005, Genes, brain, and behavior.

[47]  K. Lesch,et al.  Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree , 2002, Schizophrenia Research.

[48]  E. Michaelis,et al.  Open Access Research Article Transcriptomic Responses in Mouse Brain Exposed to Chronic Excess of the Neurotransmitter Glutamate , 2022 .

[49]  D. Blazer,et al.  The influence of lifetime depression on self-reported memory and cognitive problems: Results from the National Comorbidity Survey–Replication , 2008, Aging & mental health.

[50]  Tyson A. Clark,et al.  Nova regulates brain-specific splicing to shape the synapse , 2005, Nature Genetics.

[51]  V. Kusumakar,et al.  Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder , 2003, Biological Psychiatry.

[52]  M. Nöthen,et al.  Norepinephrine transporter (NET) promoter and 5′-UTR polymorphisms: association analysis in panic disorder , 2005, Neuroscience Letters.

[53]  K. Lesch,et al.  MLC1 Polymorphisms Are Specifically Associated with Periodic Catatonia, a Subgroup of Chronic Schizophrenia , 2007, Biological Psychiatry.

[54]  David Coghill,et al.  The genetics of attention-deficit/hyperactivity disorder , 2009, Expert review of neurotherapeutics.

[55]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[56]  C. Sommer,et al.  The functional Val158Met variant of the COMT gene is not associated with migraine with or without aura , 2006, The Journal of Headache and Pain.

[57]  H. Lipps,et al.  Inhibition of HIV-1 replication by a high-copy-number vector expressing antisense RNA for reverse transcriptase. , 1993, Gene.

[58]  P. Riederer,et al.  The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[59]  T. Wienker,et al.  Evolutionary conserved microsatellites in the promoter region of the 5-hydroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females , 2002, Journal of Neural Transmission.

[60]  B. Blencowe,et al.  An RNA map predicting Nova-dependent splicing regulation , 2006, Nature.

[61]  P. Emson,et al.  Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS. , 1996, Brain research. Molecular brain research.

[62]  J. Meyer,et al.  Reply concerning KIAA0027 (WKL1, MLC1) and psychosis: white matters , 2002, Molecular Psychiatry.

[63]  H. Lipps,et al.  The processing of macronuclear DNA sequences during macronuclear development of the hypotrichous ciliate Stylonychia lemnae. , 1993, The International journal of developmental biology.

[64]  Liang Wang,et al.  Altered small‐world brain functional networks in children with attention‐deficit/hyperactivity disorder , 2009, Human brain mapping.

[65]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[66]  K. Lesch,et al.  Short CAG repeats within the hSKCa3 gene associated with schizophrenia: results of a family‐based study , 1998, Neuroreport.

[67]  N. Craddock,et al.  Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD , 2004, Molecular Psychiatry.

[68]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[69]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[70]  B. Franke,et al.  Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[71]  Susanne Walitza,et al.  Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies , 2008, Journal of Neural Transmission.

[72]  Agnieszka Slowik,et al.  Screening for replication of genome-wide SNP associations in sporadic ALS , 2009, European Journal of Human Genetics.

[73]  B. Neale,et al.  Genome‐wide association study of response to methylphenidate in 187 children with attention‐deficit/hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[74]  C. Freitag,et al.  Rare variants of the gene encoding the potassium chloride co-transporter 3 are associated with bipolar disorder. , 2005, The international journal of neuropsychopharmacology.

[75]  H. Nakanishi,et al.  Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity , 2001, Brain Research.

[76]  Robert T. Schultz,et al.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.

[77]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[78]  D. Boomsma,et al.  Genetic and Environmental Influences on the Relation Between Attention Problems and Attention Deficit Hyperactivity Disorder , 2007, Behavior genetics.

[79]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[80]  W. Schempp,et al.  SOX20, a new member of the SOX gene family, is located on chromosome 17p13. , 1996, Cytogenetics and cell genetics.

[81]  Y. Zang,et al.  Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study , 2001, Neuroscience Letters.

[82]  Aribert Rothenberger,et al.  Genome‐wide association scan of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[83]  M. Owen,et al.  A Family Based Study Implicates Solute Carrier Family 1–Member 3 (SLC1A3) Gene in Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[84]  Ramesh Srinivasan,et al.  Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence. , 2007, Cerebral cortex.

[85]  M. Morita,et al.  Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats , 2002, Neuroscience Letters.

[86]  K. Lesch,et al.  Structural and functional characterization of the human PAX7 5'-flanking regulatory region. , 2002, Gene.

[87]  F. Rijsdijk,et al.  High Heritability for a Composite Index of Children’s Activity Level Measures , 2008, Behavior genetics.

[88]  C. Freitag,et al.  No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD , 2007, Journal of Neural Transmission.

[89]  Annemarie Poustka,et al.  The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: Alternative biallelic variation in rhesus monkeys , 2005, Journal of Neural Transmission.

[90]  Mauricio Castillo,et al.  Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[91]  K. Lesch,et al.  The brain‐specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain , 2003, Glia.

[92]  O. Haas,et al.  Mutational analysis of the SOX9 gene in campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations. , 1997, Human molecular genetics.

[93]  H. Stefánsson,et al.  Supplementary webappendix , 2018 .

[94]  D. Stephan,et al.  No missense mutation of WKL1 in a subgroup of probands with schizophrenia , 2002, Molecular Psychiatry.

[95]  D. Hellhammer,et al.  Haploinsufficiency of the SERPINA6 gene is associated with severe muscle fatigue: A de novo mutation in corticosteroid-binding globulin deficiency , 2007, Journal of Neural Transmission.

[96]  K. Lesch,et al.  A second large family with catatonic schizophrenia supports the region distally of CHRNA7 on chromosome 15q14–15 , 2003, Molecular Psychiatry.

[97]  K. Lesch,et al.  Association and linkage of allelic variants of the dopamine transporter gene in ADHD , 2007, Molecular Psychiatry.

[98]  J. Hewitt,et al.  Genetic and environmental contributions to retrospectively reported DSM-IV childhood attention deficit hyperactivity disorder , 2007, Psychological Medicine.

[99]  N. Tommerup,et al.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.

[100]  V. Russell,et al.  Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat , 2000, Behavioural Brain Research.

[101]  D. Collier,et al.  Pharmacogenetic prediction of clozapine response , 2000, The Lancet.